| WESTAT, INC. | Agricultural Research Service | 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services | $261K | 24 November 2026 | Now / imminent | Details |
| WESTAT, INC. | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $24.1M (2 orders) | 29 November 2026 | Now / imminent | Details |
| WESTAT, INC. | Department of Education | 541219 Other Accounting Services | $42.0M | 31 December 2026 | Now / imminent | Details |
| WESTAT, INC. | Defense Health Agency | 541711 Research and Development in Biotechnology | $22.2M | 31 December 2026 | Now / imminent | Details |
| WESTAT, INC. | FDA | 541820 Public Relations Agencies | $881K (2 orders) | 06 January 2027 | Now / imminent | Details |
| WESTAT, INC. | Office of the Assistant Secretary for Financial Resources | 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services | $182.8M (2 orders) | 12 January 2027 | Now / imminent | Details |
| WESTAT, INC. | Consumer Product Safety Commission | 541611 Administrative Management and General Management Consulting Services | $356K | 31 January 2027 | Now / imminent | Details |
| WESTAT, INC. | Department of Education | 541720 Research and Development in the Social Sciences and Humanities | $47.1M | 06 February 2027 | Now / imminent | Details |
| WESTAT, INC. | NIH | 541611 Administrative Management and General Management Consulting Services | $9.1M | 15 February 2027 | Now / imminent | Details |
| WESTAT, INC. | FDA | 541820 Public Relations Agencies | $143K | 28 February 2027 | Now / imminent | Details |
| WESTAT, INC. | FDA | 541820 Public Relations Agencies | $414K | 14 March 2027 | Now / imminent | Details |
| WESTAT, INC. | FDA | 541820 Public Relations Agencies | $387K (2 orders) | 22 March 2027 | Now / imminent | Details |
| WESTAT, INC. | Departmental Offices | 541611 Administrative Management and General Management Consulting Services | $3.1M | 31 March 2027 | Now / imminent | Details |
| WESTAT, INC. | Office of the Assistant Secretary for Financial Resources | 541611 Administrative Management and General Management Consulting Services | $1.6M | 31 March 2027 | Now / imminent | Details |
| WESTAT, INC. | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $605K | 31 March 2027 | Now / imminent | Details |
| WESTAT, INC. | National Science Foundation | 541611 Administrative Management and General Management Consulting Services | $2.8M | 15 April 2027 | Now / imminent | Details |
| WESTAT, INC. | Office of the Assistant Secretary for Administration and Management | 541611 Administrative Management and General Management Consulting Services | $221K | 01 May 2027 | Now / imminent | Details |
| WESTAT, INC. | FDA | 541820 Public Relations Agencies | $563K (2 orders) | 14 May 2027 | Now / imminent | Details |
| WESTAT, INC. | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $2.2M | 31 May 2027 | ~Q4 2026 | Details |
| WESTAT, INC. | Offices, Boards and Divisions | 541199 All Other Legal Services | $69K | 01 June 2027 | ~Q4 2026 | Details |
| WESTAT, INC. | Substance Abuse and Mental Health Services Administration | 541990 All Other Professional, Scientific, and Technical Services | $17.0M | 14 June 2027 | ~Q4 2026 | Details |
| WESTAT, INC. | CDC | 541611 Administrative Management and General Management Consulting Services | $15.3M | 30 June 2027 | ~Q1 2027 | Details |
| WESTAT, INC. | Office of the Assistant Secretary for Financial Resources | 541219 Other Accounting Services | $2.2M | 30 June 2027 | ~Q1 2027 | Details |
| WESTAT, INC. | Office of the Assistant Secretary for Financial Resources | 541611 Administrative Management and General Management Consulting Services | $4.7M | 26 July 2027 | ~Q1 2027 | Details |
| WESTAT, INC. | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $7.6M | 31 July 2027 | ~Q1 2027 | Details |